Bing:
A four-year, $2.7 million grant from the National Institute of Mental Health, part of the National Institutes of Health (NIH), has been awarded to Vanderbilt University Medical Center pharmacologist Jerod Denton, PhD, and his team to pave the way for potential treatments for schizophrenia and autism spectrum disorder (ASD)¹. Higher ratios of excitatory-to-inhibitory synaptic transmission are seen in both ASD and schizophrenia. Correcting this imbalance could be key to treating these disorders¹.
Denton works on potassium channels, which are found in cell membranes of virtually all organisms. Normal nerve transmission relies on the transfer of potassium ions across nerve cell membranes via these channels¹. At the heart of the study is a type of inhibitory neuron called GABAergic interneurons, which connect brain regions, playing vital roles in coordinating high-frequency brain activity¹. As a potential source of the excitatory/inhibitory imbalance in ASD and schizophrenia, evidence now points to malfunction of a type of potassium channel, Kv3.1, special to GABAergic interneurons¹.
Denton and his team will aim to develop Kv3.1 enhancers and test their efficacy in restoring the balance of neural activity in a mouse model of ASD. In latter stages of this work, they’ll focus on key brain areas, using various lab techniques to carefully fill in neurological details surrounding any targeted drug effects¹. “This grant creates opportunities for developing critically needed tool compounds to explore the role of Kv3.1 potassium channels in autism spectrum disorder and schizophrenia,” said Denton, professor of Anesthesiology and Pharmacology¹. “These are some of the most challenging and costly disorders going, and we’re excited to have this opportunity to take this work forward.” Denton’s co-investigators on the grant include Craig Lindsley, PhD, University Distinguished Professor of Pharmacology, and Brad Grueter, PhD, associate professor of Anesthesiology¹. The study is supported by NIH grant MH131721¹.
Source: Conversation with Bing, 8/17/2023
(1) Grant aids drug discovery for autism, schizophrenia. Grant aids drug discovery for autism, schizophrenia | VUMC Reporter | Vanderbilt University.
(2) August | 2023 | VUMC Reporter | Vanderbilt University. August | 2023 | VUMC Reporter | Vanderbilt University.
(3) NIH grant launches C. diff vaccine research initiative. NIH grant launches C. diff vaccine research initiative | VUMC Reporter | Vanderbilt University.
(4) VUMC receives $51 million in NIH grants to improve efficiency of … VUMC receives $51 million in NIH grants to improve efficiency of conducting clinical trials across the U.S. | VUMC Reporter | Vanderbilt University.